Table 4.
Result of Molecular dynamics studies.
| Ligand details | Simulation Time (ns) |
RMSD average value | RMSF | Important Interactions (>30%) | H bond residues (30%) | Interaction with physiologically important residues | |
|---|---|---|---|---|---|---|---|
| Grid 1 | Acarbose | 50ns | 3.15 Å | 3.0 Å | Asn501, gly 496, gln493, ser494, tyr505, gly 502, | Gln493, ser494, asn501 | Asn501, gln493 |
| Lactulose | 50ns | 3.0 Å | 5.5 Å | Insignificant interaction | |||
| Riboflavin | 50ns | 3.0 Å | 1.2 Å | Gln498,tyr505,arg403,tyr495,ser494, | Tyr505,gln498,tyr495,ser494 | Gln498 | |
| Mitoxantrone | 50ns | 3.5 Å | 4.8 Å | ARG403,GLN498, ASN501, | Asn501,gln498,gly 496,arg403 | GLN498, ASN501, | |
| Cangrelor | 50ns | 2.1 Å | 3.5 Å | Ser494,gly 496,arg403,lys417 | Arg403,ser494,lys417 | lys417 | |
| Miglitol | 50ns | 2.5 Å | 4.1 Å | Insignificant interactions | |||
| Epinephrine | 50ns | 3.8 Å | 2.8 Å | Asp364 | Asp364 | ||
| Kanamycin | 100ns | 3.45 Å | 3.2 Å | Glu484, | glu484 | Glu484 | |
| Fenoterol | 50ns | 3.2 Å | 0.8 Å | Tyr449,tyr495,tyr505,arg403 | Tyr495,arg403 | Tyr449 | |
| Grid 2 | Cangrelor | 50ns | 2.2 Å | 0.9 Å | Arg403,tyr495,glu406,lys417,arg408,gln409,thr415 | Lys417,gln409,arg408 | Lys417 |
| Diosmin | 50ns | 2.5 Å | 4.0 Å | Insignificant interaction | |||
| Amphotericin B | 50ns | 2.4 Å | Insignificant interaction | ||||
| Leucovorin | 50ns | 2.7 Å | 4.3 Å | Insignificant interaction | |||
| Amikacin | 50ns | 3.1 Å | 2.2 Å | Tyr495,tyr453,arg403lys417,glu406 | Arg403,glu406tyr453 | Lys417,tyr453 | |
| Levomefolic acid | 50ns | 3.0 Å | 1.0 Å | Glu406,ile418, lys417,tyr453 | Glu406,lys417,tyr453,ser494 | Tyr453,lys417 | |
| Caspofungin | 50ns | 2.4 Å | Insignificant interaction | ||||
| Fenoterol | 50ns | 3.3 Å | 3.8 Å | Pro491,tyr489,phe 456 | |||
| Grid 3 | Pantethinone | 50ns | 2.8 Å | 4.8 Å | Ala 372 | Asn481,pro479 | |
| Cytarabine | 50ns | 3.2 Å | 5 Å | Insignificant interaction | |||
| Ferrous ascorbate | 50ns | 2.9 Å | 3.6 Å | Insignificant interaction | |||
| Calcium ascorbate | 50ns | 2.25 Å | 3.3 Å | Insignificant interaction | |||
| Ascorbic acid | 50ns | 2.2 Å | 3.2 Å | Insignificant interaction | |||
| Ribavirin | 50ns | 2.8 Å | 4.0 Å | Insignificant interaction | |||
| Norepinephrine | 50ns | 2.15 Å | 2.5 Å | Insignificant interaction | |||
| Lamivudine | 50ns | 2.95 Å | 3.6 Å | Asn481,val 483,phe486 | Asn481,gly 482,val 483,phe486, | Phe486 | |
| Levosalbutamol | 50ns | 2.3 Å | 3.0 Å | Insignificant interaction | |||
| Epinephrine | 50ns | 2.65 Å | 4.0 Å | Insignificant interaction | |||
| Azacitidine | 50ns | 3 Å | 4.5 Å | Phe486 | Phe486,asn487 | Phe486,asn487 | |
| Pirbuterol | 50ns | 3.1 Å | 7 Å | Glu340 | Glu340 | ||
| Grid 4 | Diosmin | 50ns | 2.15 Å | 3.1 Å | Tyr489 | ||
| Mitoxantrone | 50ns | 2.5 Å | 3.0 Å | Arg403,gln498,asn501 | Asn501,gln498,arg403, | Asn501,gln498 | |
| Amikacin | 50ns | 3.15 Å | 3.8 Å | Tyr495,arg403,gly 496,glu484 | Glu484,ser494,tyr495,gly 496,gln498,asn501 | Asn501,gln498,glu484 | |
| Cangrelor | 50ns | 3.6 Å | 1.2 Å | Arg408,lys417 | Arg403,arg408,lys417, | Lys417 | |
| Fenoterol | 50ns | 3.95 Å | 7 Å | Insignificant interaction | |||
| Ribavirin | 50ns | 2.7 Å | 3.2 Å | Insignificant interaction | |||
| Gluconolactone | 50ns | 2.6 Å | 4.7 Å | Insignificant interaction | |||
| Vidarabine | 50ns | 2.6 Å | 1.0 Å | Gly496,gln498,tyr505 | Gly496,gln498,tyr505 | Gln498 | |
| Grid 5 | Norepinephrine | 50ns | 3.25 Å | 7.0 Å | Lys458,glu471,asp467,ser469 | Lys458,asp467,ser469,glu471 | |
| Miglitol | 50ns | 3.2 Å | 4.1 Å | Insignificant interaction | |||
| Nystatin (anti-fungal) | 50ns | Insignificant interaction | |||||
| Tenapanor (Used in IBS) | 50ns | 2.3 Å | Insignificant interaction | ||||
| Sodium ascorbate | 50ns | 2.9 Å | 7 Å | Leu455 | Leu455, phe 456, gln493 | Gln493 |